The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Pictured Above / (L-R) Prof. Rafi Beyar, Prof. Lior Gepstein, Technion President Prof. Uri Sivan, and Dr. Joachim Behar The Technion and Rambam Hospital are setting up a new joint Technion-Rambam Center for Artificial Intelligence in Healthcare (CAIH) that will signal a revolution in medical decision-making. The CAIH, the first joint academic-hospital AI center in Israel and one of the first in the world, will develop advanced artificial intelligence systems to analyze a patient’s condition. The center will focus on developing tools that will help physicians select, in real time, the most appropriate and accurate medical treatment for a patient….
Pictured Above / Moussa Youdim Professor Emeritus Moussa Youdim from the Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology is the recipient of the 2022 Israel Prize for Life Sciences in recognition of his pioneering, groundbreaking scientific achievements in the field of neuropharmacology. The committee noted that Prof. Youdim, “… has placed generations of undergraduates and graduates, many of whom hold key positions, in Israeli academia and in the biotechnology industry. His publications have received wide international acclaim and have won him many awards.” Technion President Professor Uri Sivan said, “It is my honor to congratulate…
Three research groups have won a unique grant from the Technion’s Human Health Initiative (THHI). The brainchild of Technion President Professor Uri Sivan, the TTHI promotes interdisciplinary research related to the worlds of health and medicine. “Human health is one of the main challenges facing humanity in the 21st century,” said President Sivan. “Like other huge challenges, a significant revolution in human health requires multidisciplinary efforts. The THHI brings together researchers from different faculties on the premise that removing boundaries between faculties and disciplines is essential to preserve the Technion’s world-class status and to meet the challenges of the 21st…
Antibiotics are a double-edged sword: on the one hand, antibiotics are essential to curing bacterial infections. On the other hand, their use promotes proliferation of antibiotic-resistant bacteria. Using genomic sequencing techniques and machine learning analysis of patient records, researchers from the Technion – Israel institute of Technology and Maccabi KSM Research and Innovation Center have developed an antibiotic-prescribing algorithm that cuts the risk of emergence of antibiotic resistance by half. The paper, published in Science, is a collaboration between the research group of Professor Roy Kishony from the Technion Faculty of Biology and the Henry and Marilyn Taub Faculty of…
Pictured Above / Professor Reut Shalgi Researchers at the Technion’s Rappaport Faculty of Medicine have discovered that the body has the capability of curing various neurodegenerative diseases, including Huntington’s, Alzheimer’s, and ALS. Unfortunately, however, the body often fails to detect the problem and activate the solution. Professor Reut Shalgi likened the situation to computer troubleshooting. Often you don’t recognize at first that something is wrong with your computer. And when you do, finding the solution is hit or miss. “It is the same with our cells,” she said. “They do not always realize there is a problem, or know how…
Photo credit: Advance Materials Magazine Patients suffering from sodium-related diseases and other conditions currently must visit a clinic or hospital for blood tests that can be painful and do not provide online or immediate results. Now, Technion researchers have developed a smart, wearable “band-aid” fitted with microneedles that continuously monitor a person’s medical condition and send the data to the patient or doctor. The research, recently featured on the cover of Advanced Materials, was led by Professor Hossam Haick, postdoctoral fellow Dr. Youbin Zheng, and Ph.D. student Rawan Omar of the Wolfson Faculty of Chemical Engineering and the Russell Berrie…
Pictured Above / Dr. Kira Radinksy / Photo credit: Omer Hacohen The last step in developing a drug or medical treatment is the clinical trial, which confirms the treatment’s efficacy in humans and its safety. While a long and expensive process, a successful clinical trial is essential to receiving approval from the FDA or other regulating authorities. Yet clinical trials have long underrepresented women, leading to misdiagnosed diseases and adverse drug reactions. A new article in the Journal of the American Medical Informatics Association (JAMIA) by researchers at the Henry and Marilyn Taub Faculty of Computer Science at the Technion…
Pictured Above / Prof. Yotam Bar-On (left) and Dina Khateeb / Photo credit: Rami Shelush, Technion Spokesperson’s Office. Although the original form of the novel coronavirus — SARS-CoV-2 — was armed with an effective system against mutations, it was not immune to them. Indeed, the virus has since “split” into variants according to differing evolutionary variables in different populations. These mutations occur in the spike protein of the virus, which allows it to penetrate the cells in our body. The development of new variants is the result of random mutations and natural selection. Most mutations do not significantly alter the…
Plenty of good news came out of coronavirus research. Scientists got a jump on developing mRNA vaccines, treatment for viruses moved quickly past Tamiflu, and researchers realized the critical importance of making findings available to the public. These were just some of the conclusions to come out of a Technion webinar moderated by Professor Roy Kishony, the Marilyn and Henry Taub Professor of Life Sciences in the Technion Faculty of Biology. Stressing the importance of an interdisciplinary approach in tackling COVID-19, Prof. Kishony called on M.D.-Ph.D. candidate Matan Levine, mathematician Associate Professor Nir Gavish, and biomedical data scientist Assistant Professor…
Pictured Above / (Left to right): Hadas Weizman, Sana Gur-Gelbard, Shani Zigman, Orit Zigman, Mor Heinrich, Marina Gabinski Six-year-old Shani has always yearned to draw, but her cerebral palsy has prevented her from lifting her hands independently for tabletop activities. In a heartwarming and inspiring turn of events, four students from the Technion’s Master’s of Industrial Design program teamed up with Shani’s mother to find a solution. They created an award-winning device that enables Shani to draw and eat independently for the first time in her life. “The importance of the device to Shani and the change it has made…
The joy of a baby coming into the world is accompanied by anxiety for this helpless little being, completely reliant on outside help to survive. This is magnified for a baby born preterm. Many premature babies with underdeveloped lungs require mechanical ventilation. The more prematurely the baby is born, the longer they will need artificial breathing. Using a 3D model of the babies’ upper airways, the research team of Professor Josué Sznitman, of the Technion Faculty of Biomedical Engineering, discovered that shear forces caused by the air jet from the mechanical ventilator can create stress and inflammation in the airway…
